MANGOCEUTICALS INC (MGRX) Stock Price & Overview

NASDAQ:MGRX • US56270V2051

Current stock price

0.39 USD
+0.05 (+14.71%)
Last:

The current stock price of MGRX is 0.39 USD. Today MGRX is up by 14.71%. In the past month the price decreased by -13.53%. In the past year, price decreased by -78.27%.

MGRX Key Statistics

52-Week Range0.162 - 2.8752
Current MGRX stock price positioned within its 52-week range.
1-Month Range0.162 - 0.491
Current MGRX stock price positioned within its 1-month range.
Market Cap
6.618M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.50
Dividend Yield
N/A

MGRX Stock Performance

Today
+14.71%
1 Week
+0.59%
1 Month
-13.53%
3 Months
-56.41%
Longer-term
6 Months -84.55%
1 Year -78.27%
2 Years -90.68%
3 Years -97.90%
5 Years N/A
10 Years N/A

MGRX Stock Chart

MANGOCEUTICALS INC / MGRX Daily stock chart

MGRX Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to MGRX. When comparing the yearly performance of all stocks, MGRX is a bad performer in the overall market: 97.61% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

MGRX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to MGRX. The financial health of MGRX is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MGRX Earnings

Next Earnings DateMay 13, 2026
Last Earnings DateApr 1, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

MGRX Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

MGRX Groups

Sector & Classification

Sub-Industry
Drug Retail
Index Membership

MGRX Financial Highlights

Over the last trailing twelve months MGRX reported a non-GAAP Earnings per Share(EPS) of -2.5. The EPS increased by 46.45% compared to the year before.


Income Statements
Revenue(TTM)456.10K
Net Income(TTM)-21.23M
Industry RankSector Rank
PM (TTM) N/A
ROA -131.95%
ROE -139.67%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%70.96%
Sales Q2Q%-10.35%
EPS 1Y (TTM)46.45%
Revenue 1Y (TTM)-25.96%

MGRX Ownership

Ownership
Inst Owners14.95%
Shares16.97M
Float15.27M
Ins Owners10.02%
Short Float %8.93%
Short Ratio0.08

About MGRX

Company Profile

MGRX logo image Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The company is advancing its proprietary antiviral compound MGX-0024. The firm offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. The company has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.

Company Info

IPO: 2023-03-21

MANGOCEUTICALS INC

15110 Dallas Pkwy, Suite 600

Dallas TEXAS US

Employees: 3

MGRX Company Website

MGRX Investor Relations

Phone: 18336264679

MANGOCEUTICALS INC / MGRX FAQ

What does MGRX do?

Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The company is advancing its proprietary antiviral compound MGX-0024. The firm offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. The company has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.


What is the stock price of MANGOCEUTICALS INC today?

The current stock price of MGRX is 0.39 USD. The price increased by 14.71% in the last trading session.


Does MANGOCEUTICALS INC pay dividends?

MGRX does not pay a dividend.


What is the ChartMill technical and fundamental rating of MGRX stock?

MGRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the employee count for MGRX stock?

MANGOCEUTICALS INC (MGRX) currently has 3 employees.


What is the market capitalization of MGRX stock?

MANGOCEUTICALS INC (MGRX) has a market capitalization of 6.62M USD. This makes MGRX a Nano Cap stock.